Clinical trial
Optimal Predilatation Treatment Before Implantation of a Magmaris Bioresorbable Scaffold In Coronary Artery Stenosis
NCT04666584 is registered in ClinicalTrials.gov with Odense University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Optimal Predilatation Treatment Before Implantation of a Magmaris Bioresorbable Scaffold In Coronary Artery Stenosis
- Lead sponsor
- Odense University Hospital
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- December 14, 2020
- Completion date
- December 31, 2024
- Enrollment
- 82 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
arterial occlusive diseases, atherosclerosis of artery, cardiovascular diseases, coronary artery disease, coronary artery stenosis, coronary disease, heart diseases, myocardial infarction, myocardial ischemia, stable angina